Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 13 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

8%

1 trials in Phase 3/4

Results Transparency

0%

0 of 4 completed trials have results

Key Signals

2 recruiting

Enrollment Performance

Analytics

Phase 2
9(81.8%)
Phase 1
1(9.1%)
Phase 3
1(9.1%)
11Total
Phase 2(9)
Phase 1(1)
Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (13)

Showing 13 of 13 trials
NCT07394270Phase 2Not Yet Recruiting

Effect of Add-on L-Arginine Therapy on Heart Failure Patients

Role: lead

NCT07338682Phase 2Recruiting

Evaluation of the Effect of L-Arginine on the Cognitive Function in Geriatric Patients

Role: lead

NCT06812585Phase 2Completed

The Effect of Metformin As an Adjuvant Therapy on Immunological Parameters in Egyptian Patients with RRMS: a Pilot Study

Role: lead

NCT06753565Phase 2Recruiting

L-carnitine Supplementation in Rheumatoid Arthritis Patients

Role: lead

NCT06458686Phase 1Not Yet Recruiting

Effect of Vitamin D Supplementation on Mental Health: An Exploratory Study on A University Students Suffering From Vitamin D Deficiency

Role: lead

NCT05693597Phase 2Completed

Evaluation of the Effect of Nigella Sativa for the Prophylaxis to Radiation Induced Dermatitis in Breast Cancer Patients

Role: lead

NCT05641246Phase 2Completed

Effect of Topical Diclofenac on Clinical Outcome in Breast Cancer Patients Treated With Capecitabine

Role: lead

NCT05735067Unknown

The Impact of Body Weight on Clinical and Immunological Outcomes in Relapse-Remitting Multiple Sclerosis Patients

Role: lead

NCT05979038Phase 3Unknown

Clinical Evaluation of the Effect of Metformin in Sepsis

Role: lead

NCT05298670Phase 2Unknown

Drug Repurposing Using Metformin for Improving the Therapeutic Outcome in Multiple Sclerosis Patients

Role: lead

NCT05692752Completed

Expression of microRNA-133a and microRNA-208b in Acute Myocardial Infarction

Role: collaborator

NCT04817904Phase 2Unknown

Evaluation of the Effect of Rosuvastatin on Cisplatin-induced Nephrotoxicity and Ototoxicity

Role: collaborator

NCT04780854Phase 2Unknown

Drug Repurposing for the Prevention of Chemotherapy-induced Peripheral Neuropathy (CIPN)

Role: collaborator

All 13 trials loaded